TFF Pharmaceuticals And 3 Other Stocks Under $5 Insiders Are Aggressively Buying

The Dow Jones closed lower on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Paramount Group

• The Trade: Paramount Group, Inc. PGRE Director Thomas Armbrust acquired a total of 20,000 shares an average price of $4.85. To acquire these shares, it cost around $97 thousand.
• What’s Happening: Paramount Group reported a rise in quarterly earnings.
• What Paramount Group Does: Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district ("CBD") submarkets of New York City and San Francisco.

Castellum

• The Trade: Castellum, Inc. CTM 10% owner Jay Wright acquired a total 10,600 shares at an average price of $1.04. The insider spent around $11.04 thousand to buy those shares.
• What’s Happening: Castellum recently reported a $500,000 equity financing.
• What Castellum Does: Castellum Inc, formerly BioNovelus Inc is engaged in acquiring and growing technology companies in the areas of information technology and cybersecurity with businesses in the public (government) and private (commercial) markets.

Check This Out: Lennar, Caleres And 3 Stocks To Watch Heading Into Tuesday

TFF Pharmaceuticals

• The Trade: TFF Pharmaceuticals, Inc. TFFP President and CEO Harlan F Weisman acquired a total of 150,000 shares at an average price of $0.88. To acquire these shares, it cost around $131.84 thousand.
• What’s Happening: TFF Pharmaceuticals posted a 2022 net loss of $31.8 million, versus a net loss of $31.0 million in 2021.
• What TFF Pharmaceuticals Does: TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform.

Don’t forget to check out our premarket coverage here

Broadway Financial

• The Trade: Broadway Financial Corporation BYFC Director William Longbrake acquired a total of 7,500 shares at an average price of $1.18. The insider spent $8.85 thousand to buy those shares.
• What’s Happening: Broadway Financial posted a profir for the fourth quarter.
• What Broadway Financial Does: Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States.